A nanoscale aqueous shunt that aims to treat mid to late-stage glaucoma.
VisiPlate is 1,000x thinner than alternative late-stage implants.
VisiPlate leverages an ultrathin nanoplate developed at the University of Pennsylvania.
VisiPlate's insertion procedure reduces operating time and makes follow-up care easier.
VisiPlate is made of alumina, a long-proven implant material that has been used in hip replacements.